So, instead -- I will laud Dr. Gerberding, now the elected Board Secretary of trade group BIO (and a member of the board of directors of NASDAQ traded Cerner, a health information technology company) -- well done! [My December 2014 backgrounder on her portfolio of increasing responsibilities, while at Kenilworth, here.]
Here's the BIO press release -- and a bit:
. . . .BIO is pleased to announce the election of John Maraganore, Ph.D., Chief Executive Officer, Alnylam Pharmaceuticals, Inc., as the new Chair of its Board of Directors for the 2017-2018 term, and the election of Julie Gerberding, Executive Vice President for Strategic Communications, Global Public Policy & Population Health & Chief Patient Officer, Merck, as its new Board Secretary. . . .
As I say -- our congrats go out to this fine bio-sciences leader (with deep history in the vaccines arena)! Onward.
नमस्ते
No comments:
Post a Comment